In this issue:
Heparin-based VTE prevention in medical inpatients
Pharmacological VTE prophylaxis and VTE in hospitals
Direct oral anticoagulants in VTE with cancer
Short-term outcomes of normotensive acute PE with high lactate
Predicting anticoagulant-related bleeding in VTE
Clinical implications of a limited negative CTPA
Prognostic value of RVEF in PAH
Iloprost reverses fibrosis in RV failure in rats
Riociguat for CTEPH
Riociguat + sildenafil in PAH
Please login below to download this issue (PDF)